| For: | Yang L, Xu X, Wang L, Zeng KB, Wang XF. Edaravone administration and its potential association with a new clinical syndrome in cerebral infarction patients: Three case reports. World J Clin Cases 2023; 11(19): 4648-4654 [PMID: 37469729 DOI: 10.12998/wjcc.v11.i19.4648] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i19/4648.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Ma Huang, Yalan Mo, Haiyun Lei, Miao Chen. Edaravone: A Possible Treatment for Acute Lung Injury. International Journal of General Medicine 2024; : 3975 doi: 10.2147/IJGM.S467891
|
| 3 |
Ziyue Wang, Bowen Lu, Hao Yang, Weijie Zhao, Xinru Kong, Chuanhao Mi, Jianlin Wu, Hong-Liang Zhang. Safety assessment of Edaravone: A real-world adverse event analysis based on the FAERS Database. PLOS One 2025; 20(10): e0335362 doi: 10.1371/journal.pone.0335362
|
